conference reports
Incidence of PCa diagnosed incidentally in specimens taken during BPH surgery
Wednesday, 23 September 2009- In 2.8–9.8% of patients (pts) undergoing TURP or prostatectomy (PR) due to benign prostate hyperplasia (BPH), final pathological evaluation (PE) reveals coexistence of prostate cancer (PCa)....
Edited by: JV
Asymptomatic inflammatory prostatitis in ageing male with LUTS
Friday, 18 September 2009- Asymptomatic inflammation as new category of prostatitis is often found during evaluation of other reproductive and prostate disorders. Kristo Ausmees, et al. (Estonia) conducted a study to determine...
Edited by: JV
Diode laser yields promising results in BPH treatment
Thursday, 30 July 2009- Vaporisation of the prostate with the use of the diode laser is a safe and effective procedure for treating patients with BPH, according to the preliminary results of a Polish study, which will be...
Edited by: ES
Turkish study examines prostate vaporisation efficiency of high power diode laser technique
Thursday, 14 May 2009- Vaporisation techniques utilizing lasers have gained wide acceptance in the management of benign prostate hyperplasia (BPH) as an alternative to transurethral resection of the prostate. High power diode...
Edited by: JV
Erectile dysfunction drug may offer aid for BPH patients
Friday, 8 May 2009- A drug for erectile dysfunction significantly improved symptoms of benign prostatic hyperplasia (BPH) in a randomised clinical trial. The findings were reported during the recent American Urological...
Edited by: JV
Silodosin provides symptom relief for BPH patient
Wednesday, 6 May 2009- Data presented at the American Urological Association's (AUA) Annual Conference show that silodosin (Rapaflo) produces rapid and sustained improvements of both irritative and obstructive urinary...
Edited by: JV
Frequency-volume charts in older men: changes in parameter values with advancing age
Friday, 17 April 2009- Dutch researchers who conducted a study in BPH and medical therapy won first prize for the best abstract in the non-oncology category at the recent 24th Annual EAU Congress held in Stockholm, Sweden. Their...
Edited by: JV
EAU Research Foundation launches LUTS-BPH Registry
Wednesday, 18 March 2009- The European Association of Urology Research Foundation (EAURF) is launching this year a European registry project that aims to evaluate the impact and management of Lower Urinary Tract Symptoms (LUTS)...
By Joel Vega
18th European Urology Forum in Davos: state-of-the-art lecture on BPH/LUTS
Thursday, 12 February 2009- Professor Francois Desgrandchamps (France) delivered a state-of-the-art lecture on minimally invasive therapy for BPH/LUTS at the recently concluded 18th European Urology Forum in Davos, Switzerland,...
Edited by: LB
Phase 2 studies show benefit of investigational BPH drug NX-1207
Friday, 14 November 2008 - Nymox Pharmaceutical Corporation’s investigational benign prostatic hyperplasia (BPH) drug NX-1207 provided significant improvement in urinary symptoms for men afflicted with diseases, according to...
Edited by: JV/PR
